Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Improved Case of Recurred and Metastatic Ascending Colon Cancer by Combination of Oriental Medical Therapy and FOLFIRI Chemotherapy

산삼약침과 FOLFIRI 항암화학요법의 병행으로 호전된 전이성 대장암 환자 1례

  • Received : 2013.01.17
  • Accepted : 2013.02.20
  • Published : 2013.02.25
Download PDF
⟨ Previous Next ⟩

Abstract

This study is aimed to investigate the effects of intravenous Cultivated Wild Ginseng Pharmacopuncture(CWGP) and the FOLFIRI chemotherapy combination on recurred and metastatic ascending colon cancer patient. A 42-years-old man was diagnosed as ascending colon adenocarcinoma on 9th Mar. 2011. After performing right hemicolectomy and 12 cycles of FOLFOX chemotherapy recurrence at hemicolectomy site and metastases in liver, spleen and lungs were found on 7th Feb. 2012. Intravenous CWGP were performed during total 12 cycles of FOLFIRI chemotherapy from 3rd Mar. 2012 to 27th Sep. 2012. The effects and toxicities of CWGP and FOLFIRI chemotherapy combination were evaluated with PET torso(AA) and National Cancer Institute-Common Toxicity Criteria. The tumor mass in the splenic hilum and liver S4 was disappeared and multiple pulmonic lymph nodules were decreased in size. The recurred lesion on the site of right hemicolectomy showed no changes. During the treatment the patient had no toxicity over grade 1.

Keywords

References

  1. 박재갑, 방영주, 하성환. 종양학. 서울, 일조각, p 371, 155, 161, 2012.
  2. 국립암센터 중앙암등록본부. 2010년 국가암등록통계. 서울:보건복지부. p 9, 2012.
  3. Nabil Ismaili. Treatment of colorectal liver metastases. World J Surg Oncol. 9: 154, 2011. https://doi.org/10.1186/1477-7819-9-154
  4. 전국한의과대학 본초학교수. 본초학. 서울, 영림사, pp 531-533, 1992.
  5. 권기록, 임세영, 이수진. 산삼약침이 Colon26-L5 암세포주를 이용한 간전이 모델의 항암 및 면역증진에 미치는 영향. 대한침구학회지 23(1):121-134, 2006.
  6. 안영민, 박희수, 권기록. 산삼과 산양삼 추출물의 항암 및 항산화 효능. 대한약침학회지 10(1):5-16, 2007.
  7. 방선휘, 권기록, 유화승, 산삼약침 혈맥주입을 시행한 비소세포성폐암 환자 2례. 대한약침학회지 11(2):13-19, 2008.
  8. 박봉기, 조종관, 권기록, 유화승. 6개월간 산삼약침요법을 시행 받은 IIIB기 편평세포폐암 환자에 대한 증례보고. 대한약침학회지 10(3):143-147, 2007.
  9. 임창락, 권강, 서영찬, 방선휘, 김성수, 성신. 한방치료와 XELOX 요법을 병행하여 호전된 간, 폐 전이 대장암 환자 1례. 대한암한의학회지 17(1):17-25, 2012.
  10. 국립암센터. 암정보. 제2판. 고양시, 국립암센터 출판부, p 178, 2006.
  11. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D. Global cancer statistics. CA Cancer J Clin. 61(2):69-90, 2011. https://doi.org/10.3322/caac.20107
  12. Scheithauer, W., Rosen, H., Kornek, G.V., Sebesta, C., Depisch, D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ306(6880):752-755, 1993. https://doi.org/10.1136/bmj.306.6880.752
  13. Mayer, R.J. Moving beyond fluorouracil for colorectal cancer. N Engl J Med. 343(13):963-964, 2000. https://doi.org/10.1056/NEJM200009283431309
  14. David J Gallagher, Nancy Kemeny. Metastatic Colorectal Cancer:From Improved Survival to Potential Cure. Oncology. 78:237-248, 2010. https://doi.org/10.1159/000315730